NDAINJECTIONINJECTABLE
Approved
Feb 1999
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2
Data completeness
3/8 — Basic
UVADEX (methoxsalen) by Teva is photoabsorption [moa]. First approved in 1999.
Drug data last refreshed 5h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
UVADEX (methoxsalen) is a photoactivated radical generator administered by injection that works through photoabsorption mechanisms. It is indicated for extracorporeal photochemotherapy and related photoactivated therapies in select hematologic and dermatologic conditions. The drug functions as a photosensitizing agent that generates reactive oxygen species when exposed to UVA light.
LOE Approaching
With LOE approaching and low competitive pressure (30), this product likely operates as a niche specialty asset requiring focused expertise rather than large-scale commercial infrastructure.
Mechanism of Action
Photoabsorption
Pharmacologic Class:
Photoactivated Radical Generator
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (2)
Extracorporal Photopheresis With UVADEX Plus Standard Steroid Treatment for High Risk Acute Graft-versus-host Disease
Started May 2020
24 enrolled
Acute-graft-versus-host Disease
Extracorporeal Photopheresis (ECP) With Methoxsalen for Chronic Graft Versus Host Disease (cGVHD)
Started Nov 2011
60 enrolled
Chronic Graft Versus Host Disease
Career Relevance
With zero linked job postings and LOE approaching, UVADEX represents a career opportunity best suited for professionals experienced in niche specialty products and lifecycle management rather than growth-stage portfolio building. This role demands deep technical knowledge of photochemotherapy and reimbursement expertise in rare indications, with emphasis on operational excellence and market defense.
Worked on UVADEX at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.